Cytodyn Inc (CYDY)

[Mymani]

I wrote to Richard harris at npr in response to his Eli Lilly article.
He promptly responded as below and i responded with some Cytodyn’s major milestones.
Not sure he wiill take this up but some of the longs can try to write to him if you think fit:

I wrote”
Thanks Richard! Absolutely!

Here is the link to their dsmc assesment of their recent ph 3 interim analysis for efficacy of severe to critical covid patients:

https://www.cytodyn.com/investors/news-events/press-releases/detail/477/cytodyn-receives-positive-dsmc-recommendation-after-interim

Safety:
https://www.cytodyn.com/investors/news-events/press-releases/detail/456/cytodyn-receives-positive-dsmc-recommendation-for

Here is the link to their positive results of phase 2 of mild to moderate patients:

https://www.cytodyn.com/investors/news-events/press-releases/detail/458/cytodyn-announces-clinically-significant-top-line-results

https://www.cytodyn.com/investors/news-events/press-releases/detail/462/cytodyn-requests-fast-track-approval-for-covid-19

https://www.cytodyn.com/investors/news-events/press-releases/detail/472/cytodyns-phase-2-study-of-leronlimab-for

I appreciate your work in this time of need!
Please let me know if you have more questions.

Thanks!
“
Harris <[e-mail]> wrote:

I generally consider covering drugs when they have positive phase 2/3 results and/or get EUA. Feel free to let me know about truly major milestones.

Richard

?On 10/28/20, 11:42 PM, I wrote:

Mr Harris, in response to your article on the Eli Lilly Anti body drug, i would ask you to cover a company called Cytodyn which is the first company to have its drug Leronlimab -another monoclonal antibody get a safety and efficacy positive recommendation from the Data Safety Monitoring Commitee (DSMC) for it ‘s phase 3 severe covid patients on interim
Analysis. Being a small
Company it hardly gets any attention.
Appreciate your help!
Mukund

Sent from my iPhone